Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
380 studies found for:    Endometrial Cancer: Clinical Trials
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Completed Radiation Therapy or Observation Only in Treating Patients With Endometrial Cancer Who Have Undergone Surgery
Condition: Endometrial Cancer
Intervention: Radiation: radiation therapy
2 Suspended Prospective Randomised Phase II Trial Evaluating Adjuvant Pelvic Radiotherapy Using Either IMRT or 3-Dimensional Planning for Endometrial Cancer. ICORG 09-06
Conditions: Endometrial Cancer;   Gastrointestinal Complications;   Radiation Toxicity;   Urinary Complications
Intervention: Radiation: 45 Gy/25 fractions
3 Unknown  A Phase II Trial of Adjuvant Radiotherapy Combined With Chemotherapy for Patients With High-risk Endometrial Cancer
Condition: Prosthesis Survival
Interventions: Radiation: radiotherapy;   Drug: Cisplatin;   Drug: Cisplatin and Doxorubicin and Cyclophosphamide;   Drug: Paclitaxel and Carboplatin
4 Recruiting Trial Between Two Follow up Regimens With Different Test Intensity in Endometrial Cancer Treated Patients
Condition: Endometrial Cancer
Interventions: Procedure: Intensive/Low-Risk Treatment (IA G1; IA G2);   Procedure: Intensive/High-Risk Treatment (≥ IA G3);   Procedure: Minimalist/Low-Risk Treatment (IA G1; IA G2);   Procedure: Minimalist/High-Risk Treatment (≥ IA G3)
5 Active, not recruiting Randomized Trial of Radiation Therapy With or Without Chemotherapy for Endometrial Cancer
Condition: Endometrial Cancer
Interventions: Radiation: Radiation Therapy;   Drug: cisplatin;   Drug: carboplatin;   Drug: Paclitaxel
6 Completed Clinical Trial of Ridaforolimus Compared to Progestin or Chemotherapy for Advanced Endometrial Carcinoma (MK-8669-007 AM6)
Condition: Endometrial Cancer
Interventions: Drug: ridaforolimus;   Drug: medroxyprogesterone acetate tablets OR megestrol acetate;   Drug: chemotherapy
7 Not yet recruiting Trial of Letrozole +/- Palbociclib in Metastatic Endometrial Cancer
Condition: Endometrial Cancer
Interventions: Drug: Palbociclib;   Drug: Letrozole
8 Active, not recruiting Phase I/IIa Trial of Folate Binding Protein Vaccine in Ovarian Cancer
Conditions: Ovarian Cancer;   Endometrial Cancer;   Fallopian Cancer;   Peritoneal Cancer
Interventions: Biological: E39 peptide vaccine;   Other: Clinical tracking for disease progression/recurrence
9 Completed Trial of Vascular Endothelial Growth Factor (VEGF), Bevacizumab, in Combination With Cytotoxic Chemotherapy for Endometrial Cancer
Condition: Endometrial Carcinoma
Intervention: Drug: carboplatin, paclitaxel, and bevacizumab
10 Recruiting Single Arm Trial With Combination of Everolimus and Letrozole in Treatment of Platinum Resistant Relapse or Refractory or Persistent Ovarian Cancer/Endometrial Cancer
Conditions: Ovarian Cancer;   Endometrial Cancer
Intervention: Drug: everolimus and letrozole
11 Completed 2D Versus 3D Radical Laparoscopic Hysterectomy for Endometrial Cancer: a Prospective Randomized Trial
Condition: Endometrial Cancer
Interventions: Procedure: 3D Laparoscopy;   Procedure: Standard Laparoscopy
12 Not yet recruiting Safety and Efficacy of Metronomic Cyclophosphamide, Metformin and Olaparib in Endometrial Cancer Patients
Condition: Recurrent Endometrial Cancer
Interventions: Drug: Olaparib;   Drug: metformin;   Drug: metronomic cyclophosphamide
13 Not yet recruiting Selective Targeting of Adjuvant Therapy for Endometrial Cancer (STATEC)
Condition: Endometrial Cancer
Interventions: Procedure: Abdominal surgery;   Procedure: Lymphadenectomy
14 Completed Letrozole in Treating Women With Recurrent or Metastatic Endometrial Cancer
Condition: Endometrial Cancer
Intervention: Drug: letrozole
15 Completed Ridaforolimus in Treating Patients With Recurrent Metastatic and/or Locally Advanced Endometrial Cancer
Condition: Endometrial Cancer
Interventions: Drug: ridaforolimus;   Genetic: gene expression analysis;   Other: immunohistochemistry staining method;   Other: laboratory biomarker analysis
16 Completed
Has Results
Temsirolimus in Treating Patients With Metastatic or Locally Advanced Recurrent Endometrial Cancer
Conditions: Endometrial Adenocarcinoma;   Endometrial Adenosquamous Cell Carcinoma;   Endometrial Clear Cell Carcinoma;   Endometrial Papillary Serous Carcinoma;   Recurrent Endometrial Carcinoma;   Stage IIIA Endometrial Carcinoma;   Stage IIIB Endometrial Carcinoma;   Stage IIIC Endometrial Carcinoma;   Stage IVA Endometrial Carcinoma;   Stage IVB Endometrial Carcinoma
Interventions: Drug: temsirolimus;   Other: laboratory biomarker analysis
17 Completed Surgery With or Without Lymphadenectomy and Radiation Therapy in Treating Patients With Endometrial Cancer
Condition: Endometrial Cancer
Interventions: Procedure: adjuvant therapy;   Procedure: conventional surgery;   Radiation: brachytherapy;   Radiation: radiation therapy
18 Terminated Clinical Trial of PM00104 (Zalypsis®) in Patients With Advanced and/or Metastatic Endometrial or Cervical Cancer Previously Treated With One Line of Systemic Chemotherapy
Conditions: Uterine Cervical Cancer;   Endometrial Cancer
Intervention: Drug: Zalypsis ( PM00104)
19 Completed Diet and Physical Activity in Uterine Cancer Survivors
Condition: Endometrial Neoplasms
Intervention: Behavioral: Shape-Up following cancer treatment
20 Recruiting Carboplatin-Paclitaxel ± Bevacizumab in Advanced (Stage III-IV) or Recurrent Endometrial Cancer
Condition: Stage III-IV or Recurrent Endometrial Cancer
Interventions: Drug: Bevacizumab;   Drug: Carboplatin AUC 5+Paclitaxel 175 mg/mq q 21 for 6-8 cycles

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.